Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 72

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 72
---
lying Shares
to be transferable pursuant to such program.

4.22
If any Purchaser becomes involved in any capacity in any Proceeding by or against any Person who is a shareholder of the Company (except
as a result of sales, pledges, margin sales and similar transactions by such Purchaser to or with any current shareholder), solely as
a result of such Purchaser’s acquisition of the Securities under this Agreement, the Company will reimburse such Purchaser for its
reasonable legal and other expenses (including the cost of any investigation preparation and travel in connection therewith) incurred
in connection therewith, as such expenses are incurred. The reimbursement obligations of the Company under this paragraph shall be in
addition to any liability which the Company may otherwise have, shall extend upon the same terms and conditions to any Affiliates of the
Purchasers who are actually named in such action, proceeding or investigation, and partners, directors, agents, employees and controlling
persons (if any), as the case may be, of the Purchasers and any such Affiliate, and shall be binding upon and inure to the benefit of
any successors, assigns, heirs and personal representatives of the Company, the Purchasers and any such Affiliate and any such Person.
The Company also agrees that neither the Purchasers nor any such Affiliates, partners, directors, agents, employees or controlling persons
shall have any liability to the Company or any Person asserting claims on behalf of or in right of the Company solely as a result of acquiring
the Securities under this Agreement.

4.23 . From the date hereof, for so long as a Purchaser holds any Preferred Shares, or any Common Shares that are not registered
for resale in a registration statement or for which may not be sold under Rule 144 without manner of sale and volume restrictions, in
the event that the Company issues or sells any Common Shares or Common Shares Equivalents, if a Purchaser then holding outstanding Securities
reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to such investors than
are the terms and conditions granted to the Purchasers hereunder, upon notice to the Company by such Purchaser within five (5) Trading
Days after disclosure of such issuance or sale, the Company shall amend the terms of this transaction as to such Purchaser only so as
to give such Purchaser the benefit of such more favorable terms or conditions. This Section 4.23 shall not apply with respect to an Exempt